Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11912738 Neuroactive steroids and their methods of use

Patent 11912738 was granted and assigned to SAGE Therapeutics on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119127380

Patent Inventor Names

Maria Jesus Blanco-Pillado0

Francesco G. Salituro0

Marshall Lee Morningstar0

Date of Patent

February 27, 2024

Patent Application Number

183342090

Date Filed

June 13, 2023

Patent Citations

‌

US Patent 11236121 Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid

‌

US Patent 8569275 Steroids having 7-oxgen and 17-heteroaryl substitution

‌

US Patent 9512165 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

‌

US Patent 11643434 Neuroactive steroids and compositions thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11912738 Neuroactive steroids and their methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API